OurCongressPublic Data • Non-Partisan
Built to help voters quickly verify how officials vote — district first, party second. All information is sourced from official public records.
← Back to bills
HR. 1143 · 119th Congress

Medicare IVIG Access Enhancement Act of 2025

In committee

This bill has not become law. Status shown reflects the latest official action.

See what this could mean for your district

Save your district in Account to view district-specific context for this bill.

Set my district

Bill details

Introduced: 2/7/2025
Status: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Bill ID: 119hr1143
Latest action: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Summary

Introduced in House

Medicare IVIG Access Enhancement Act of 2025 This bill provides for Medicare coverage of in-home administration of intravenous immune globulin to treat chronic inflammatory demyelinating polyneuropathy (CIDP) or multifocal motor neuropathy. (CIDP is an autoimmune condition that causes symptoms such as muscle weakness and numbness; multifocal motor neuropathy is a variant of CIDP that only causes asymmetric muscle weakness.)

Source: BILLSUM · Summary date: 2/7/2025

District impact notes

1 notes
NEUTRAL
3/17/2026

The Medicare IVIG Access Enhancement Act of 2025 aims to provide Medicare coverage for in-home administration of intravenous immune globulin for certain autoimmune conditions. • This bill could impact local healthcare providers by potentially increasing the demand for in-home treatment services. • It may also affect patients and families in the district who are managing chronic conditions, as it could change how they receive necessary therapies. • A consideration for implementation could be the logistics of ensuring qualified healthcare professionals are available to administer treatments in home settings. AI-generated from official bill summary and plain-English note; verify with official text.

Related votes

Roll calls that reference this bill in official data.

0 roll calls
No related roll calls found yet for this bill.

Primary sources

Official links to verify details. (No interpretation.)

Summary source label: BILLSUM
Congress.gov bill →GovInfo bill text (BILLS) →GovInfo summaries (BILLSUM) →OurCongress methodology →
About this data
  • OurCongress is non-partisan by design. We do not add political interpretation or advocacy.
  • Bill data and official summaries come from GovInfo and Congress.gov. Some bills do not have published summaries yet.
  • District impact notes (when shown) are AI-generated from official bill metadata/summaries to improve readability. They are not official government language.
  • This page updates automatically via a daily ingestion pipeline.

About this data

Non-partisan by design
OurCongress provides plain-English context without endorsements, political interpretation, or advocacy.
Official sources
Data is sourced from official government records (e.g., Congress.gov, GovInfo, Clerk of the House, and the U.S. Senate).
AI-generated text
Some sections may be AI-generated from official summaries/metadata to help readability. AI output can be imperfect—verify with primary sources.
Last updated: 3/17/2026Source: BILLSUMBill: 119hr1143Learn more →